Publication — IRIC AML with EVI1 rearrangements are characterized by SF3B1 and IKZF1 mutations and distinct expression of MECOM isoforms. Date de publication 1er août 2014 Chercheur(euse)s Lavallée VP, Boivin I, Armstrong RN, Lemieux S, Gendron P, Hebert J, Sauvageau G Référence PubMed Exp. Hematol. 2014;42(8 Suppl):S44 ID PubMed 25106277 Affiliation Institute for Research in Immunology and Cancer, l’Université de Montréal, Montréal, Quebec, Canada; Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.